World-Class Biopharmaceutical Training for Academia and Industry - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

World-Class Biopharmaceutical Training for Academia and Industry

The driving motivation behind Ireland's National Institute for Bioprocessing Research and Training (NIBRT) is to help the development of the biopharmaceutical, by developing comprehensive research and training programs for both academic students and industry professionals. By ensuring the creation and sustainability of the biopharmaceutical workforce with superior skills and competencies, the promise of more effective biotherapeutic innovations addressing the world's most challenging diseases is becoming a reality.

NIBRT provides a “one stop shop” for thousands of trainees worldwide, and offers a dynamic catalogue of course content from which unique training solutions are built for clients. NIBRT delivers holistic training programs in a realistic GMP-simulated, fully operational manufacturing environment and cutting-edge analytical laboratory suite. All training programmes can be customized to meet a client’s particular requirements.

NIBRT Key Features:

  • Purpose-built, multifunctional facility replicating the most modern industrial bioprocessing environment
  • Pilot plant consisting of extensive upstream, downstream and fill-finish facilities
  • A complete bioanalytical laboratory for hands-on scientific training of 'fit-for-purpose' biopharmaceutical analysis, including protein and peptide characterization
  • Also offer extensive course content on existing and upcoming U.S. and European drug regulations.

Get the most comprehensive overviews of the concepts, strategies and techniques – on all aspects of bioprocessing. Book your course today.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here